drugset / Trial / NCT04289883

Summary

Based on in vitro studies identifying changes in food structures potential to delay digestion as well as results from animal studies showing potential of these foods to decrease appetite, nano-particulated whey protein and high molecular weight whey protein-alginate coacervates were chosen to be investigated in humans. Thereby, the aim of this short-term study is to investigate if nano-particulated whey protein has appetite reducing effects in humans compared to non-particulated whey protein (Part 1) as well as if high molecular weight whey protein-alginate coacervates have appetite reducing effects in humans compared to calcium alginate (Part 2).

Timeline

Start
2020-04-25
Primary completion
2020-06-30
Completion
2020-06-30

Outcome

Outcome not reported

Stopped: “The Covid-19 pandemic that made it impossible to conduct within the timeframe.”

Drugs

EvaluationDrugModalityDoseRoute
Subject High molecular weight whey protein-alginate coacervates Protein / enzyme biologic — —
Subject Nano-particulated whey protein Protein / enzyme biologic — —
Subject calcium alginate Unknown — —
Subject non-particulated whey protein Protein / enzyme biologic — —

Indications

No indication recorded.